Clazosentan
Sponsors
Idorsia Pharmaceuticals Ltd.
Conditions
Aneurysmal Subarachnoid HemorrhageHealthy Subjects
Phase 1
A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan
CompletedNCT03596294
Start: 2018-07-19End: 2018-08-03Updated: 2018-10-23
A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function
CompletedNCT03657446
Start: 2018-09-18End: 2018-10-26Updated: 2018-11-20
Phase 2
Phase 3
Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
CompletedNCT00558311
Start: 2007-12-14End: 2010-07-13Updated: 2020-02-17
Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain
CompletedNCT03585270
Start: 2019-02-03End: 2022-11-18Updated: 2024-01-10